Regulatory Approvals & Licensing
Track recurring approval, licensing, and rule-change catalysts across regulatory markets.
RegulatoryScheduled
Next catalyst: Regulatory Approvals & Licensing · October 1, 2026 · October 1, 2026 at 3:59 AM
Compare-ready catalysts
1
These upcoming catalyst instances already carry approved cross-source linkage, so compare/alignment value remains available inside the recurring family.
Source footprint
4
The recurring family inherits the source footprint of its linked catalysts rather than inventing a separate data model.
Recurring cadence
Scheduled
Cadence stays descriptive and lightweight in v1 so recurring research surfaces remain easy to reason about.
How this family is grouped
This recurring layer stays conservative: a catalyst only joins this family when its title or linked-market family clearly matches these signals.
FDA approvalSEC changeLicense / reauthorization
Sources
The recurring family inherits the source footprint of its linked catalysts rather than inventing a separate data model.
KALSHI
LIMITLESS
MANIFOLD MARKETS
POLYMARKETUpcoming catalyst instances
These upcoming catalyst instances reuse the current catalyst layer and preview the linked prediction markets directly on the page.
Oct 1, 2026, 3:59 AMFamily cluster
Regulatory Approvals & Licensing · October 1, 2026
2 linked markets·1 Sources
KALSHILinked markets
Will the FDA approve cytisinicline for smoking cessation?
KALSHIWhen will FISA be reauthorized again?
KALSHIDec 31, 2026, 12:00 AMFamily cluster
Regulatory Approvals & Licensing · December 31, 2026
7 linked markets·2 Sources
Gap live
MANIFOLD MARKETSPOLYMARKETLinked markets
FDA approves a psychedelic for medical use in 2026?
POLYMARKETFDA approves Daraxonrasib this year?
POLYMARKETWho will Trump announce as next FDA commissioner?
POLYMARKETJan 1, 2027, 3:59 AMCompare-ready catalysts
Regulatory Approvals & Licensing · January 1, 2027
23 linked markets·3 Sources
1 approved matchGap live
KALSHIMANIFOLD MARKETSPOLYMARKETLinked markets
When will it first be possible to rent an autonomous vehicle to drive between cities in North America without a license?
MANIFOLD MARKETSUS grants license for new nuclear reactor before 2027?
KALSHIFDA decision: Oveporexton by Takeda (in 2026)
KALSHIJan 3, 2027, 4:00 AMFamily cluster
Regulatory Approvals & Licensing · January 3, 2027
2 linked markets·1 Sources
Gap live
KALSHILinked markets
College Football SEC Championship Winner
KALSHICollege Football SEC Championship Game Qualifiers
KALSHIJan 7, 2027, 3:00 PMFamily cluster
Regulatory Approvals & Licensing · January 7, 2027
4 linked markets·2 Sources
KALSHIMANIFOLD MARKETSLinked markets
SEC Teams to Win 10+ Regular Season Games
KALSHISEC Conference Championship Matchup
KALSHISEC: Receiving Yards Leader
KALSHIFeb 7, 2027, 3:00 PMFamily cluster
Regulatory Approvals & Licensing · February 7, 2027
3 linked markets·1 Sources
KALSHILinked markets
SEC Regular Season: Top 3 Finishers
KALSHISEC Regular Season: Top 5 Finishers
KALSHISEC Regular Season: Top 4 Finishers
KALSHIRecent catalyst instances
Recent instances stay visible here when the current data still supports them, so the recurring family has context beyond the next catalyst.
Aug 1, 2026, 3:59 AMFamily cluster
Regulatory Approvals & Licensing · August 1, 2026
3 linked markets·2 Sources
KALSHIPOLYMARKETLinked markets
FDA decision: Gedatolisib by Celcuity Inc. (July 2026)
KALSHIWill the FDA approve gedatolisib for advanced breast cancer?
KALSHIFISA Section 702 reauthorized by…?
POLYMARKETJul 23, 2026, 12:00 AMFamily cluster
Regulatory Approvals & Licensing · July 23, 2026
2 linked markets·1 Sources
POLYMARKETLinked markets
FDA approves Sanofi's Subcutaneous Sarclisa?
POLYMARKETFDA approves Elevar Therapeutics' Rivoceranib + camrelizumab?
POLYMARKETJul 8, 2026, 11:59 PMFamily cluster
Regulatory Approvals & Licensing · July 8, 2026
2 linked markets·1 Sources
MANIFOLD MARKETSLinked markets
How many of the DoE Reactor Pilot Program projects will achieve criticality by 2026-07-04?
MANIFOLD MARKETSWhich DoE Reactor Pilot Program reactors will achieve criticality by 2026-07-04?
MANIFOLD MARKETSJul 1, 2026, 3:59 AMFamily cluster
Regulatory Approvals & Licensing · July 1, 2026
5 linked markets·1 Sources
KALSHILinked markets
FDA decision: Cytisinicline by Achieve Life Sciences (June 2026)
KALSHIFDA decision: Roflumilast (ARQ-151) by Arcutis Biotherapeutics (June 2026)
KALSHIWhen will the FDA reclassify BPC-157 to Category 1?
KALSHIJun 30, 2026, 12:00 AMFamily cluster
Regulatory Approvals & Licensing · June 30, 2026
3 linked markets·2 Sources
LIMITLESSPOLYMARKETLinked markets
FDA approves Viridian Therapeutics' Veligrotug?
POLYMARKETFDA approves Ionis' Olezarsen?
POLYMARKETBinance receives MiCA license by June 30, 2026?
LIMITLESSJun 29, 2026, 12:00 AMFamily cluster
Regulatory Approvals & Licensing · June 29, 2026
2 linked markets·1 Sources
POLYMARKETLinked markets
FDA approves Unicycive's Oxylanthanum carbonate?
POLYMARKETFDA approves Arcutis' Zoryve cream?
POLYMARKET